Spotlights

Home/Spotlights

Spotlight: Big3Bio Announces Upcoming Launch of Philadelphia as a New Region of Coverage; Will Rebrand as Big4Bio

- Big4Bio:Philly to Recap Life Science Developments in the Greater Philadelphia Region; To Launch During BIO International Convention in Philadelphia in June - All “Big3Bio” Regional Sites of Boston, SFBay, San Diego to Come Together Into New “Big4Bio.com” Website With Philadelphia to Be Included BigBio Communications is proud to announce the upcoming expansion and rebranding [...]

March 6th, 2019|

Spotlight: Advance Biotech Grant Program

Unlock your molecule’s potential. Apply to the US and Canada Advance Biotech Grant Program Your promising molecule requires resources and support to realize it’s potential. Our Advance Biotech Grant Program, 6th edition, is open to biotech start-up companies in US and Canada to help you accelerate to clinic faster. Apply now for a chance to win [...]

February 1st, 2019|

Spotlight: Biotech Companies in the “Big 3” Regions Rake in the Cash

  BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is showcasing a series of reports and other resources focusing on financing and dealmaking. This feature is from DealForma, the biopharma database providing you [...]

November 13th, 2018|

Spotlight: What Small and Emerging Companies Need When Entering Into Dealmaking Discussions

BioWeekSF will soon be here again -- January 6-11, 2019 -- the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation,  the week's premium online guide, BioWeekSF.com, is sponsoring a series of viewpoints and more from leaders and professionals involved in life sciences/healthcare dealmaking. As Chair of Foley Hoag's Licensing & [...]

October 14th, 2018|

MassBio’s 2018 Industry Snapshot – Boston/Cambridge Leads the Way

Introduction of press release from MassBio: "August 29 - The Massachusetts Biotechnology Council (MassBio) released its 2018 Industry Snapshot report, which shows that Massachusetts biotechs dominated the IPO market in 2017, accounting for nearly half of all US-based biotech IPOs (48%), up from 30% in 2016. 2018 has already outpaced 2017 in terms of total Massachusetts IPOs [...]

September 3rd, 2018|

Spotlight: First Coast Tech Hubs Gather @ RESI Boston

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series The First Coast Innovator’s Gathering is a new component of the Redefining Early Stage Investments (RESI) Conference Series which was requested by the investors and strategic channel partners who routinely attend RESI. Many of these partners wanted LSN to bring the “earliest stage” [...]

August 23rd, 2018|

Spotlight: BIOWeek:Boston 2018

BIOWeek:Boston 2018 The Complete Guide to the Week of the BIO International Convention June 3-8, 2018 Big3Bio Releases The First Version of BIOWeek:Boston 2018, The Complete Guide to the Week of #BIO2018       SAN FRANCISCO, CA–(May 25, 2018)–Big3Bio, the leading aggregator service for the top biotech hubs in the US—Boston, San Francisco Bay [...]

May 27th, 2018|

May Financial Focus: Boston Area a Hot-Bed for Biopharma Startups

By Marie Daghlian VC funding for Boston area biotech companies is on fire and its momentum shows no signs of slowing up. Boston area biotech and health-related companies raised $1.58 billion in 32 deals in the first quarter of 2018. That compares favorably with the $1.59 billion raised in Q4 2017 in 42 deals, and [...]

May 14th, 2018|

Spotlight Q&A with Rob Neville, CEO, Savara Pharmaceuticals

About Savara Pharmaceuticals: Savara Inc. (NASDAQ: SVRA) is an orphan lung disease company. Savara's pipeline comprises a number of late stage therapeutics each targeting difficult to treat lung diseases. Rob Neville CEO, Savara Pharmaceuticals For people not familiar with Savara, can you provide a brief overview and focus? Neville: Savara was founded in [...]

April 2nd, 2018|
X